After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Ocular Therapeutix Inc is $1.22B. A total of 1.47 million shares were traded on the day, compared to an average of 1.01M shares.
In the most recent transaction, Dugel Pravin sold 21,475 shares of OCUL for 6.87 per share on Feb 24 ’25. After the transaction, the insider now owns 3,520,318 company shares. In a previous transaction on Feb 24 ’25, Heier Jeffrey S. sold 3,061 shares at 6.87 per share. OCUL shares that Chief Scientific Officer owns now total 265,998.
Among the insiders who sold shares, Kaiser Peter disposed of 3,009 shares on Feb 24 ’25 at a per-share price of $6.87. This resulted in the Chief Development Officer holding 210,078 shares of OCUL after the transaction. In another insider transaction, Nayak Sanjay sold 1,895 shares at $6.84 per share on Feb 24 ’25. Company shares held by the Chief Strategy Officer now total 283,485.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, OCUL has a high of $11.77 and a low of $4.06.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. OCUL’s latest balance sheet shows that the firm has $164.16M in Cash & Short Term Investments as of fiscal 2021. There were $58.98M in debt and $26.34M in liabilities at the time. Its Book Value Per Share was $2.00, while its Total Shareholder’s Equity was $88.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OCUL is Buy with a score of 5.00.
